{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T15:58:48Z","timestamp":1776355128236,"version":"3.51.2"},"reference-count":46,"publisher":"Frontiers Media SA","funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2016.00267","type":"journal-article","created":{"date-parts":[[2016,8,21]],"date-time":"2016-08-21T23:04:46Z","timestamp":1471820686000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":53,"title":["Biomarkers in DILI: One More Step Forward"],"prefix":"10.3389","volume":"7","author":[{"given":"Mercedes","family":"Robles-D\u00edaz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inmaculada","family":"Medina-Caliz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camilla","family":"Stephens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ra\u00fal J.","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Isabel","family":"Lucena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2016,8,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1111\/liv.12836","article-title":"Pharmacogenetic testing in idiosyncratic drug-induced liver injury: current role in clinical practice.","volume":"35","author":"Aithal","year":"2015","journal-title":"Liver Int."},{"key":"B2","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1038\/clpt.2011.58","article-title":"Case definition and phenotype standardization in drug-induced liver injury.","volume":"89","author":"Aithal","year":"2011","journal-title":"Clin. Pharmacol. Ther."},{"key":"B3","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1053\/j.gastro.2005.05.006","article-title":"Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period.","volume":"129","author":"Andrade","year":"2005","journal-title":"Gastroenterology"},{"key":"B4","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1002\/hep.26294","article-title":"Mechanistic biomarkers provide early and sensitive detection of acetaminophen-induced acute liver injury at first presentation to hospital.","volume":"58","author":"Antoine","year":"2013","journal-title":"Hepatology"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/j.jhep.2011.12.019","article-title":"Molecular forms of HMGB1 and keratin-18 as mechanistic biomarkers for mode of cell death and prognosis during clinical acetaminophen hepatotoxicity.","volume":"56","author":"Antoine","year":"2012","journal-title":"J. Hepatol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1093\/toxsci\/kfp235","article-title":"High-mobility group box-1 protein and keratin-18, circulating serum proteins informative of acetaminophen-induced necrosis and apoptosis in vivo.","volume":"112","author":"Antoine","year":"2009","journal-title":"Toxicol. Sci."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1002\/hep.25873","article-title":"Circulating mircroRNAs in exosomes indicate hepatocyte injury and inflammation in alcoholic, drug-induced and inflammatory liver disease.","volume":"56","author":"Bala","year":"2012","journal-title":"Hepatology"},{"key":"B8","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1111\/j.1365-2036.2011.04982.x","article-title":"Serum proteomic profiling in patients with drug-induced liver injury.","volume":"35","author":"Bell","year":"2012","journal-title":"Aliment. Pharmacol. Ther."},{"key":"B9","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/0168-8278(90)90124-A","article-title":"Criteria of drug-induced liver disorders. Report of an international consensus meeting.","volume":"11","author":"Benichou","year":"1990","journal-title":"J. Hepatol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.jhep.2013.05.030","article-title":"The metabolomic window into hepatobiliary disease.","volume":"59","author":"Beyo\u011flu","year":"2013","journal-title":"J. Hepatol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1067\/mcp.2001.113989","article-title":"Biomarkers and surrogate endpoints: preferred definitions and conceptual framework.","volume":"69","author":"Biomarkers Definitions Working Group","year":"2001","journal-title":"Clin. Pharmacol. Ther."},{"key":"B12","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1002\/hep.20800","article-title":"Outcome and prognostic markers in severe drug-induced liver disease.","volume":"42","author":"Bj\u00f6rnsson","year":"2005","journal-title":"Hepatology"},{"key":"B13","doi-asserted-by":"publisher","first-page":"5551","DOI":"10.1093\/emboj\/cdg516","article-title":"Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion.","volume":"22","author":"Bonaldi","year":"2003","journal-title":"EMBO J."},{"issue":"e97249","key":"B14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0097249","article-title":"Identification of metabolites, clinical chemistry markers and transcripts associated with hepatotoxicity.","volume":"9","author":"Buness","year":"2014","journal-title":"PLoS ONE"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1053\/j.gastro.2015.03.006","article-title":"Features and outcomes of 899 patients with drug-induced liver injury: the DILIN prospective study.","volume":"148","author":"Chalasani","year":"2015","journal-title":"Gastroenterology"},{"issue":"18396","key":"B16","doi-asserted-by":"publisher","DOI":"10.3402\/jev.v1i0.18396","article-title":"Cellular stress conditions are reflected in the protein and RNA content of endothelial cell-derived exosomes.","volume":"1","author":"de Jong","year":"2012","journal-title":"J. Extracell. Vesicles"},{"key":"B17","first-page":"1105","article-title":"Mildly elevated liver transaminase levels in the asymptomatic patient.","volume":"71","author":"Giboney","year":"2005","journal-title":"Am. Fam. Physician"},{"key":"B18","doi-asserted-by":"publisher","first-page":"621","DOI":"10.3892\/ijmm_00000173","article-title":"Detection of the mitochondrial and catalytically active alanine aminotransferase in human tissues and plasma.","volume":"23","author":"Glinghammar","year":"2009","journal-title":"Int. J. Mol. Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1007\/s11306-011-0329-9","article-title":"Serum UPLC-MS\/MS metabolic profiling in an experimental model for acute-liver injury reveals potential biomarkers for hepatotoxicity.","volume":"8","author":"Gonzalez","year":"2012","journal-title":"Metabolomics"},{"key":"B20","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/clpt.2012.40","article-title":"The effects of heparins on the liver: application of mechanistic serum biomarkers in a randomized study in healthy volunteers.","volume":"92","author":"Harrill","year":"2012","journal-title":"Clin. Pharmacol. Ther."},{"key":"B21","doi-asserted-by":"publisher","first-page":"11326","DOI":"10.1021\/ac402390q","article-title":"Pattern recognition analysis for hepatotoxicity induced by acetaminophen using plasma and urinary 1H NMR-based metabolomics in humans.","volume":"85","author":"Kim","year":"2013","journal-title":"Anal. Chem."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1002\/hep.21976","article-title":"Keratins let liver live: mutations predispose to liver disease and crosslinking generates Mallory-Denk bodies.","volume":"46","author":"Ku","year":"2007","journal-title":"Hepatology"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1053\/j.gastro.2012.09.008","article-title":"Sterile inflammation in the liver.","volume":"143","author":"Kubes","year":"2012","journal-title":"Gastroenterology"},{"key":"B24","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/S0960-9822(02)00809-6","article-title":"Identification of tissue-specific microRNAs from mouse.","volume":"12","author":"Lagos-Quintana","year":"2002","journal-title":"Curr. Biol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1093\/toxsci\/kfw001","article-title":"A systemic strategy for screening and application of specific biomarkers in hepatotoxicity using metabolomics combined with ROC curves and SVMs.","volume":"150","author":"Li","year":"2016","journal-title":"Toxicol. Sci."},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1111\/liv.13174","article-title":"Elevated levels of circulating CDH5 and FABP1 in association with human drug-induced liver injury.","author":"Mikus","year":"2016","journal-title":"Liver Int."},{"issue":"e48366","key":"B27","doi-asserted-by":"publisher","DOI":"10.1371\/journalpone.0048366","article-title":"Comprehensive miRNA expression analysis in peripheral blood can diagnose liver disease.","volume":"7","author":"Murakami","year":"2012","journal-title":"PLoS ONE"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.3892\/ijmm.2012.1106","article-title":"Isoform-specific alanine aminotransferase measurement can distinguish hepatic from extrahepatic injury in humans.","volume":"30","author":"Rafter","year":"2012","journal-title":"Int. J. Mol. Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1111\/liv.12834","article-title":"The value of serum aspartate aminotransferase and gamma-glutamyl transpeptidase as biomarkers in hepatotoxicity.","volume":"35","author":"Robles-Diaz","year":"2015","journal-title":"Liver Int."},{"key":"B30","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1053\/j.gastro.2014.03.050","article-title":"Use of Hy\u2019s law and a new composite algorithm to predict acute liver failure in patients with drug-induced liver injury.","volume":"147","author":"Robles-Diaz","year":"2014","journal-title":"Gastroenterology"},{"key":"B31","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/nature00858","article-title":"Release of chromatin protein HMGB1 by necrotic cells triggers inflammation.","volume":"418","author":"Scaffidi","year":"2002","journal-title":"Nature"},{"key":"B32","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1093\/toxsci\/kft009","article-title":"Assessment of emerging biomarkers of liver injury in human subjects.","volume":"132","author":"Schomaker","year":"2013","journal-title":"Toxicol. Sci."},{"issue":"S293","key":"B33","article-title":"Pro-Euro-DILI registry: a collaborative effort to enhance the understanding of DILI.","volume":"64(Suppl. 2)","author":"Slim","year":"2016","journal-title":"J. Hepatol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.jhep.2011.01.031","article-title":"Serum metabolomics reveals \u03b3-glutamyl dipeptides as biomarkers for discrimination among different forms of liver disease.","volume":"55","author":"Soga","year":"2011","journal-title":"J. Hepatol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1002\/hep.24538","article-title":"Circulating microRNAs as potential markers of human drug-induced liver injury.","volume":"54","author":"Starkey Lewis","year":"2011","journal-title":"Hepatology"},{"key":"B36","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.csbj.2014.08.001","article-title":"Identification of a metabolic biomarker panel in rats for prediction of acute and idiosyncratic hepatotoxicity.","volume":"10","author":"Sun","year":"2014","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"B37","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1111\/liv.12322","article-title":"Keratin-18 and microRNA-122 complement alanine aminotransferase as novel safety biomarkers for drug-induced liver injury in two human cohorts.","volume":"34","author":"Thulin","year":"2014","journal-title":"Liver Int."},{"key":"B38","doi-asserted-by":"publisher","first-page":"3792","DOI":"10.1021\/pr500462f","article-title":"Metabolomic profiling of autoimmune hepatitis: the diagnostic utility of nuclear magnetic resonance spectroscopy.","volume":"13","author":"Wang","year":"2014","journal-title":"J. Proteome Res."},{"key":"B39","doi-asserted-by":"publisher","first-page":"4402","DOI":"10.1073\/pnas.0813371106","article-title":"Circulating microRNAs, potential biomarkers for drug-induced liver injury.","volume":"106","author":"Wang","year":"2009","journal-title":"Proc. Natl. Sci. U.S.A."},{"key":"B40","doi-asserted-by":"publisher","first-page":"12169","DOI":"10.1073\/pnas.1412608111","article-title":"Circulating microRNA profiles in human patients with acetaminophen hepatotoxicity or ischemic hepatitis.","volume":"111","author":"Ward","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B41","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1002\/hep.23574","article-title":"Quantitative analyses and transcriptomic profiling of circulating messenger RNAs as biomarkers of rat liver injury.","volume":"51","author":"Wetmore","year":"2010","journal-title":"Hepatology"},{"key":"B42","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1093\/toxsci\/kfr321","article-title":"Identification of urinary microRNA profiles in rats that may diagnose hepatotoxicity.","volume":"125","author":"Yang","year":"2012","journal-title":"Toxicol. Sci."},{"key":"B43","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.taap.2015.02.013","article-title":"Potential of extracellular microRNAs as biomarkers of acetaminophen toxicity in children.","volume":"284","author":"Yang","year":"2015","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.toxlet.2014.01.013","article-title":"Circulating extracellular vesicles as a potential source of new biomarkers of drug-induced liver injury.","volume":"225","author":"Yang","year":"2014","journal-title":"Toxicol. Lett."},{"key":"B45","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.ajhg.2008.09.012","article-title":"Population-based genome-wide association studies reveal six loci influencing plasma levels of liver enzymes.","volume":"83","author":"Yuan","year":"2008","journal-title":"Am. J. Hum. Genet."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1373\/clinchem.2010.147850","article-title":"Plasma microRNA-122 as a biomarker for viral-, alcohol-, and chemicalrelated hepatic diseases.","volume":"56","author":"Zhang","year":"2010","journal-title":"Clin. Chem."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T17:05:23Z","timestamp":1498323923000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/Article\/10.3389\/fphar.2016.00267\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,22]]},"references-count":46,"URL":"https:\/\/doi.org\/10.3389\/fphar.2016.00267","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,22]]}}}